The assesssment of efficacy and safety of Irreversible Electroporation (IRE) for patients with hepatocellular carcinoma (HCC)
Phase 1
- Conditions
- Hepatocellualr carcinoma
- Registration Number
- JPRN-UMIN000013732
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with other malignancy 2. Pregnancy case 3. Patients with severe heart brain disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the effect and usefulness of therapy
- Secondary Outcome Measures
Name Time Method the safety